Researchers from the Murdoch Institute have identified the genetic mechanism behind their peanut allergy remission therapy, with the potential for it to be applicable across other allergies.
“What we found was profound differences in network connectivity patterns between children who were allergic and those who were in remission,” said lead researcher Dr. Mimi Tang on May 24. The institute previously developed a combinational treatment of probiotic and oral peanut immunotherapy that could successfully induce remission in around half of the participants.
Around 75 percent of all participants were able to eat a serving of peanuts without any symptoms after the treatment whilst the remaining quarter of participants were observed to have increased tolerance to the allergen….